Cargando…
Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development
Thyroid-associated ophthalmopathy (TAO) is the most common extrathyroidal manifestation of toxic diffuse goiter (Graves' disease), also known as Graves' ophthalmopathy/orbitopathy. As an organ-specific autoimmune disease, the pathogenesis of TAO is still unclear. In recent years, great pro...
Autores principales: | Huang, Yazhuo, Fang, Sijie, Zhang, Shuo, Zhou, Huifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585473/ https://www.ncbi.nlm.nih.gov/pubmed/33110747 http://dx.doi.org/10.4103/tjo.tjo_18_20 |
Ejemplares similares
-
The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
por: Huang, Yazhuo, et al.
Publicado: (2018) -
A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy
por: Wang, Yang, et al.
Publicado: (2018) -
Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022) -
Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017) -
Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?
por: Lahooti, Hooshang, et al.
Publicado: (2010)